Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 8 of 19
- Annora Pharma Private Limited recalls Pitavastatin TabletsFDAPresence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
- Nitrous Oxide Chargers: Sold for Inhalation Without Market Authorization (DIN)Health CanadaProduct safety
- Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl CapsulesFDAFailed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
- Disinfectant Spray & Wipe Cleaner: Affected lots contain solution that do not meet the labelled strengthHealth CanadaProduct safety
- Nitrous Oxide Chargers: Sold for Inhalation Without Market Authorization (DIN)Health CanadaProduct safety
- Nextleaf Labs Ltd. recalls Glacial Gold – Anytime 1:1 Fuzzy Mango due to packaging and labelling issueHealth CanadaLabelling and packaging
- Mohamed Hagar recalls Mojo Max Fusion XXXFDAMarketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
- StuffbyNainax recalls MRFDAMarketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
- ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pillsFDAMarketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
- ACME UNITED CORPORATION recalls Med Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) and 19 moreFDACGMP Deviations
- Teva Pharmaceuticals USA, Inc recalls Metoprolol Succinate Extended-Release TabletsFDAFailed Dissolution Specifications
- Harbin Jixianglong Biotech Co., Ltd. recalls SemaglutideFDACGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before…
- Cipla USA, Inc. recalls Nilotinib CapsulesFDAFailed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual…
- The Harvard Drug Group LLC recalls Midodrine Hydrochloride TabletsFDADefective container; inadequately sealed blister packaging.
- Radnostix recalls Sodium Iodide (I-131) SolutionFDAPresence of Particulate Matter: Due to production issues
- MYLAN PHARMACEUTICALS INC recalls Amnesteem (Isotretinoin) CapsulesFDAFailed Dissolution Specifications
- HTO Nevada Inc. dba Kirkman recalls FIVE-STAR and 1 moreFDAStability Data Does Not Support Expiry Date.
- New Life Pharma LLC recalls Semaglutide Inj. and 2 moreFDALack of Assurance of Sterility
- Rising Pharma Holding, Inc. recalls Product labelFDAFailed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
- VENLAFAXINE XR: out of specificationHealth CanadaProduct quality
- IXCHIQ (chikungunya vaccine, live, attenuated) and the Risk of Serious Adverse Reactions in Medically Frail Individuals 65 Years of Age and OlderHealth CanadaNew safety information - Product safety - Adverse reaction
- KETOROLAC: The weight is out of specification in the affected lots.Health CanadaProduct quality
- APO-BRIMONIDINE-TIMOP: The weight is out of specification in the affected lot.Health CanadaProduct safety
- Importation of US-Authorized Vasopressin Injection, USP, 20 units/mL (For IV Infusion) Due to the Current Shortage of Canadian-Authorized Vasopressin Injection, USP, 20 units/mL (For IM or SC Administration)Health CanadaProduct safety - Packaging - Supply
- Agebox recalls Agebox iKids-Growth (Night Formula) and 1 moreFDAMarketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
- Wizcure Pharmaa Private Limited recalls BioGlo Fluorescein Sodium Ophthalmic Strips USP and 6 moreFDALack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
- LEO PHARMA INC recalls AdbryFDALack of Assurance of Sterility: due to the presence of particulate matter in one unit from the lot, which lab tests have identified as wool fiber.
- Slate Run Pharmaceuticals recalls Eptifibatide InjectionFDALabeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing.…
- AvKARE recalls Amantadine HClFDAFailed Dissolution Specifications: This recall has been initiated due to an Out of Specification finding in dissolution.
- Importation of Portuguese-authorized Lentocilin S 1200 1 200 000 IU / 4 mL, due to the current shortage of Canadian-authorized Bicillin L-A 1 200 000 IU / 2 mLHealth CanadaProduct safety - Packaging - Supply
- Champignons et Adaptogènes: Affected lot contains concentrations for certain ingredients that differ from the concentration on the label.Health CanadaDosage
- Galaxie Brands Corporation recalls Cannabis Cartel QUADS Dubai Inspired Chocolate due to contamination with aflatoxinsHealth CanadaProduct contamination
- CEFAZOLIN FOR INJECTION : Vials may be underfilled in the affected lot.Health CanadaProduct quality
- Teva-Indomethacin: Out of specificationHealth CanadaProduct quality
- Amerisource Health Services LLC recalls Oxycodone Hydrochloride TabletsFDADefective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
- Unichem Pharmaceuticals USA Inc. recalls Doxazosin TabletsFDATablets/Capsules Imprinted with Wrong ID
- F.H. INVESTMENTS, Inc. (dba Asteria Health) recalls Testosterone and 7 moreFDAPresence of Foreign substance - potential presence of metal particulate matter
- Pro Numb Tattoo Numbing Spray LLC recalls Pro Numb Tattoo Numbing SprayFDACGMP deviations
- McKesson recalls UDENYCAFDATemperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment…
- Meitheal Pharmaceuticals, Inc recalls Cetrorelix Acetate for Injection (Kit)FDADefective Delivery System: Missing or duplicated needles within the injection kit
- Fresenius Kabi Compounding, LLC recalls thiamine HCl and 3 moreFDALack of Assurance of Sterility
- APO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolutionHealth CanadaProduct quality
- Seasonique, Seasonale tablets: Affected lot(s) may not contain the correct amount of tablets (missing blister card)Health CanadaProduct quality
- Green Lumber Holdings, LLC recalls Green Lumber Natural Fuel For Men capsuleFDAMarketed without an Approved NDA/ANDA: FDA analysis found this product to contain tadalafil
- HANDELNINE GLOBAL LLC recalls Rheumacare capsulesFDACGMP Deviations: product found to contain lead.
- Unichem Pharmaceuticals USA Inc. recalls Bisoprolol Fumarate and Hydrochlorothiazide tabletsFDACGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
- Granules Pharmaceuticals Inc. recalls Trazodone HydrochlorideFDAPresence of Foreign Tablets/Capsules
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Diclofenac SodiumFDAFailed Viscosity Specifications: Out of Specification (OOS) [slightly lower than the limit] result in viscosity for Diclofenac Sodium Gel, 3%.
- MAR-AMLODIPINE: affected lots may contain tablet(s) of Midodrine 2.5mg tablets.Health CanadaProduct safety
- Cefazolin for Injection: Affected lots are packaged with the incorrect Linear barcode on inner and outer bag labels.Health CanadaLabelling